21 September 2025 : Clinical Research
tDCS and Speech Therapy in Aphasia Treatment: A Multicenter Comparative Study of Efficacy
Zofia Twardochleb
ABCDEF 1, Marta Szczepańska ABCDEF 1, Maciej M. Miś CEF 2, Marcin Miś CEF 2, Adam Druszcz DEF 3,4, Małgorzata Paprocka-Borowicz ADEG 5,6*, Joanna Rosińczuk ADEFG 7
DOI: 10.12659/MSM.950237
Med Sci Monit 2025; 31:e950237
Table 7 Adverse effects and tolerability of transcranial direct current stimulation (tDCS) during the study.
| Adverse event | Group I (tDCS) | Group III (tDCS+SLT) | Overall (n=60) |
|---|---|---|---|
| Mild scalp irritation (%) | 15% | 11% | 13% |
| Transient headache (%) | 10% | 7% | 8% |
| tDCS – transcranial direct current stimulation; SLT – speech and language therapy. | |||